James Shannon
Joined
May 2015 (also served February 2010–April 2012)
Current Role
Chairman of the Board
Compensation Committee member
Current Experience
Director: Horizon Therapeutics plc
Director: Kyowa Kirin (NA)
Director: Immodulon Therapeutics Limited
Director: ProQR Therapeutics NV
Director: MyTommorows
Past Experience
Chief Medical Officer: GlaxoSmithKline
Global Head of Pharma Development: Novartis AG
Director: Biotie
Director: Circassia
Director: Crucell
Director: Endocyte
Director, Interim Chief Executive Officer: Cerimon Pharmaceuticals
Education
Queen’s University of Belfast: undergraduate and postgraduate degrees in medicine and cardiology